Dorsey Wright & Associates Moon Lake Immunotherapeutics Transaction History

Dorsey Wright & Associates

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$48.35 - $61.26 $1,788 - $2,266	-37 Reduced 3.33%	1,074 $61,000
Q2 2023 Jul 26, 2023	BUY	$19.01 - $51.79 $2,110 - $5,748	111 Added 11.1%	1,111 $56,000
Q1 2023 Apr 19, 2023	BUY	$11.03 - $23.7 $11,030 - $23,700	1,000 New	1,000 $21,000

129

58.2M

103K

79.7K

Ticker MLTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,925,600
Market Cap $1.77B
Description
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

Stay updated on Dorsey Wright & Associates with notifications on news.